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Abstract.  Lymphocyte function-associated antigen-1 
(LFA-1) is a leukocyte and lymphoma cell surface pro- 
tein that promotes intercellular adhesion. We have pre- 
viously shown that the invasion of hepatocyte cultures 
by lymphoma cells is inhibited by anti-LFA-1 antibod- 
ies (Roos,  E.,  and F.  E  Roossien.  1987.  J.  Cell Biol. 
105:553-559).  In addition, we now report that LFA-1 
is also involved in invasion of lymphoma cells into 
fibroblast monolayers. 
To investigate the role of LFA-1  in metastasis of 
these lymphoma cells, we have generated mutants that 
are deficient in LFA-1 cell surface expression because 
of impaired synthesis of either the ~  or ~  subunit 
precursor of LFA-1. We identified at least three distinct 
mutant clones. The invasive potential of the mutant 
cells in vitro, in both hepatocyte and fibroblast cul- 
tures, was considerably lower than that of parental 
cells. 
The metastatic potential of the mutants was much re- 
duced, indicating that LFA-I expression is required for 
efficient metastasis formation by certain lymphoma 
cells. 
W 
'HEN metastatic tumor cells invade tissues from the 
blood they have to adhere to both extracellular ma- 
trix and cells in those tissues. Since extracellular 
matrix is scarce in the liver, adhesion to cells is probably the 
most important. Certain lymphomas readily metastasize to 
the liver and invade extensively between hepatocytes. Such 
iymphoma cells are highly invasive in cultures of isolated he- 
patocytes (Roos et al.,  1981). We have recently shown this 
invasion to be inhibited by an antibody against LFA-I, appar- 
ently because of its interference with adhesion to the upper 
surface of the hepatocytes (Roos and Roossien, 1987),  sug- 
gesting that LFA-1 is important for lymphoma metastasis. 
LFA-1 is expressed by leukocytes but not by nonhemato- 
poietic cells (Kiirzinger et al.,  1981). It was discovered with 
a monoclonal antibody that inhibited killing by cytotoxic T 
cells and natural killer cells by interfering with adhesion to 
the target cell, a step that precedes and is necessary for lethal 
hit delivery (for review see Martz,  1987).  LFA-1 is now 
known to be involved in many adhesion-related phenomena 
associated with immune response (Springer et al., 1987). In 
addition to interleukocyte adhesion, LFA-1 partially medi- 
ates binding of activated tumoricidal macrophages to tumor 
cells (Strassman et al.,  1986),  and of lymphocytes to en- 
dothelial cells (Mentzer et al.,  1986),  fibroblasts (Dustin et 
al.,  1986),  and high endothelium of lymph node postcapil- 
lary venules (Pals et al.,  1988). 
LFA-1 belongs to a family of three leukocyte adhesion pro- 
teins,  including Mac-1 and  p150,95. These  are  heterodi- 
meric glycoproteins consisting of a unique c~ subunit (180, 
170, and 150 kD, respectively) noncovalently associated with 
a common 95-kD ~ subunit. Both c~ and B subunits of this 
family show considerable homology with those of the inte- 
grins-proteins that mediate adhesion to extracellular matrix 
components (Hynes, 1987; Kishimoto et al.,  1987a; Law et 
al., 1987). The importance of the LFA-I/Mac-1/p150,95 fam- 
ily of proteins is demonstrated in patients suffering from leu- 
kocyte adhesion deficiency, a life-threatening genetic disease 
(for review see Anderson and Springer,  1987).  The leuko- 
cytes of these  patients  are  defective in  several  adhesion- 
related functions as a result of a deficiency in surface expres- 
sion of LFA-1, Mac-l, and p150,95. This deficiency originates 
primarily from defects in the common/~-chain (Kishimoto 
et al.,  1987b). 
The role of LFA-1 in metastasis might be tested by in vivo 
administration of anti-LFA-1  antibody. However, such treat- 
ment would not only block adhesion of the lymphoma cells 
but also multiple LFA-l-dependent processes important for 
both specific and nonspecific host resistance to the tumor 
cells. In particular, macrophage and natural killer function 
would be  affected. To circumvent this problem,  we have 
generated a  set of LFA-l-deficient lymphoma mutant cell 
lines, and now show that these cells exhibit reduced invasive 
potential in vitro, as well as attenuated metastatic capacity 
in vivo. 
Materials and Methods 
Cells and Culture Conditions 
Generation and properties of mouse T cell hybridomas were reported else- 
where  (Roos  et  al.,  1985).  Hybridomas  were  cultured  in  RPMI  1640 
medium supplemented with 10 mM Hepes, 10% NCTC 135 (Flow Labora- 
tories, Ayeshire, UK), 35 mM NaHCO3, 2 mM glutamine, 0.5 mM 2-mer- 
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bovine insulin (Sigma Chemical Co., St.  Louis, MO),  1% antibiotic an- 
timycotic solution (Gibco, Daisly, UK), and 10% FCS (Flow Laboratories). 
Rat hepatocytes were isolated as described previously (Roos and Van de 
Pavert,  1982).  Cells were cultured in  16-mm multiwell plates (Primaria; 
Falcon Labware, Oxnard, CA) at 2x105 cells/well in DME supplemented 
with 5 #g/ml bovine insulin. Before seeding, the wells were coated with 5% 
newborn calf serum (Sera Laboratories, Sussex, UK) in PBS. After 2 h, the 
cells were washed twice with DME supplemented with 5 ~g/ml bovine insu- 
lin  and  10%  newborn  calf serum,  and  cultured overnight in  the  same 
medium. 
Rat embryo fibroblast 208 F-cells (Miiller and MOiler,  1984)  were cul- 
tured in DME supplemented with 10% newborn calf serum, and were used 
for assays between passages 5 and  15. 
Antibodies 
Monoclonal antibodies M17/4,  M1/9.3,  and  M5/49,  directed  against the 
LFA-1 cechain, T-200,  and Thy.1,  respectively, were kindly donated by Dr. 
E. Martz (University of Massachusetts). The antibodies were purified from 
hybridoma supernatant by affinity chromatography on Sepharose-coupled 
goat  anti-rat  IgG  antibodies,  as  described  before  (Roos  and  Roossien, 
1987). 
To prepare a polyclonal anti-LFA-I antiserum, the antigen was purified 
from TAM2D2 T  cell hybridoma cells. Cells (5  ×  108) were lysed at a 
density of 107/ml  in lysis buffer, containing 0.5%  NP-40, 4  mM MgCI2, 
150 mM NaCI, and 40 mM Tris-HCl, pH 7.6, supplemented with protease 
inhibitors: 1 mM PMSF, 20 #g/ml soybean trypsin inhibitor (Sigma Chemi- 
cal Co.), and 50 Klett U/ml Trasylol (Bayer, Leverkusen, FRG). After 15 
min at 4°C, cell debris was removed by a  15-min centrifugation in a mini- 
fuge. The lysate was precleared twice with 0.5 ml packed beads of Sepha- 
rose CL-4B (Pharmacia Fine Chemicals, Uppsala, Sweden) for 16 and 2 h, 
respectively. The LFA-1 protein was immunoprecipitated by a 2-h incuba- 
tion with 0.5 ml packed beads of Sepharose-coupled M17/4 antibody (1 mg 
antibody/ml beads). The beads were washed with 0.5%  NP-40 in 50 mM 
Tris-HCI, pH 7.6, 150 mM NaCI, 5 mM EDTA, 1 mM PMSF (wash buffer). 
The antigen was eluted from the beads with 0.5%  Triton X-100 in 0.1  M 
glycine-HCl, pH 2.5,  neutralized with  1 M  Tris buffer, dialyzed against 
PBS,  and concentrated by  Amicon pressure dialysis.  Analysis by  SDS- 
PAGE and subsequent silver staining demonstrated that the isolated LFA-I 
was highly purified.  Rabbits were immunized by intramuscular injection 
with 100/~g of purified LFA-1 in complete Freund's adjuvant and boostered 
three times with 50-80 #g LFA-1 in incomplete Freund's adjuvant. From 
125I-surface-labeled  TAM2D2 cell lysates, the polyclonal antiserum immu- 
noprecipitated exclusively the LFA-1 ~  and/~ subunits of 180 and 97 kD, 
respectively (not shown). Also from lysates denatured in SDS, both chains 
were precipitated, showing that the antiserum contained antibodies directed 
against both subunits. 
Generation  and Selection of TAM2D2 Mutants 
TAM2D2 cells in culture medium were incubated with 0.4 mg/ml ethyl 
methanesulfonate for 24 h at 37°C. Cells were centrifuged, suspended in 
fresh medium, and cultured for 3 d to recuperate from the treatment with 
the mutagen. Mutants were selected by panning on culture plates coated with 
M17/4 anti-LFA-1 monoclonal antibody. The plates had been prepared by 
subsequent incubations with 3 % glularaldehyde (30 min), PBS (1 min), 50 
#g/ml poly-L-lysine (30 min), and PBS. This sequence of incubations was 
repeated once, and after a final wash with PBS, the plates were incubated 
with M17/4 antibody (1.5/zg/ml) for 30 min at 20°C, followed by subsequent 
incubations with 5 % BSA in PBS (30 min at 20°C) and culture medium (30 
min at 37°C). Mutated cells were incubated on the coated plates for 30 min 
at 37°C. Nonadhered cells were removed by gently shaking the plates and 
collecting the upper medium, taking care not to disturb the layer of cells 
attached to the substrate. Cells were expanded, and the panning procedure 
was repeated. After 6-10 rounds of selection, the cells were cloned by limit- 
ing dilution. 
Biosynthetic Labeling 
Cells (5  x  106) were pulse-labeled for 60 rain at 37°C with 50/~Ci of 
[35S]methionine in  methionine-free MEM  (modified)  with  Earle's  salts 
(EMEM;  Flow  Laboratories)  supplemented  with  10%  FCS  (dialyzed 
against PBS).  Half of the cells were harvested and stored as a  pellet at 
-70°C. The remaining cells were diluted with 2 vol of EMEM containing 
80/~g/ml methionine, chased for  15 h, and stored as a  frozen pellet. 
Immunoprecipitations 
Labeled cells (106) were lysed in 0.25 ml lysis buffer. After 15 min on ice, 
cell debris was removed by a  10-min centrifugation in a minifuge. Lysates 
were precleared by subsequent incubations with 1 #l normal rabbit serum 
(overnight) and 2 #l packed beads of protein A-Sepharose (Pharmacia Fine 
Chemicals; 30 min). After a 2-h incubation with 2 #l rabbit anti-LFA-I anti- 
serum, the immune  complexes were precipitated with 4 p.I Protein A-Sepha- 
rose (30 min). The precipitates were washed five times with wash buffer, 
after which the immune complexes were eluted with 1.0% Triton X-100 in 
0.1  M  glycine-HCl, pH 2.5,  neutralized with  1 M  Tris,  l:l  diluted with 
twice-concentrated solubilization buffer (Laemmli,  1970),  denatured for 
5 min at 100°C, and subjected to SDS-PAGE on 7.5 % polyacrylamide gels. 
Invasion Assay in Hepatocyte Cultures 
Adhesion and invasion were quantitated by light microscopy, as described 
previously (Roos and Van de Pavert, 1982). 5  ×  105 tumor cells in 500 #1 
DME were added per hepatocyte culture in a 16-ram well. When anti-LFA-1 
antibodies were used (final concentration: 1 #g/ml), they were preincubated 
with the tumor cells for 30 min at 20°C and remained present during incuba- 
tion with hepatocytes. The cultures were incubated for 4 h at 37°C, washed 
once with PBS, fixed with glutaraldehyde, dehydrated, and scraped from the 
dish. The culture fragments were pelleted and embedded in Epon.  l-/.tm- 
thick sections were stained and observed with a light microscope. Hepato- 
cyte nuclei and infiltrated tumor cells were counted. As a measure of inva- 
sion, the infiltration index was calculated (infiltrated tumor cells/hepatocyte 
nuclei).  Measurements were performed at least three times. 
Invasion Assay in Fibroblast Cultures 
Invasiveness in fibroblast cultures was quantitated essentially according to 
the method of Verschueren et al. (1987) and Collard et al.  (1987).  Tumor 
cells were washed with PBS, suspended in 25 ml of MEM supplemented 
with 10 mM Hepes, and incubated, with or without anti-LFA-1 monoclonal 
antibodies (final concentration:  1/.tg/ml), for 30 rain at 20°C. The cell sus- 
pension was then added to confluent rat embryo fibroblast monolayers in 
10-cm  2 wells and incubated for 4  h at 37°C and 5%  CO2.  Subsequently, 
noninfiltrated  tumor cells  were  removed by  repeated  washing, and  the 
monolayers were fixed with 2% paraformaldehyde in PBS. Infiltrated cells 
were easily recognized in the phase-contrast microscope as dark and flat- 
tened cells. The number of infiltrated cells was counted in 10 different 0.27- 
mm  2 areas,  distributed at  random over the monolayers.  From  this,  the 
number of infiltrated cells per well was calculated, and invasiveness  was ex- 
pressed as the percentage of added cells. 
DNA Analysis 
Approximately 105 cells were fixed with 70% ethanol, treated with 0.1% 
RNase and 0.1% pepsin (Collard and Smets, 1974),  stained with a mixture 
of ethidium bromide (I0/~g/ml) and Hoechst 33258 (4/~g/ml), and analyzed 
in a Phywe ICP-11 flow cytophotometer. Trout red blood cells were included 
as an internal standard. DNA contents were expressed as a percentage of 
that of BW5147  cells. 
lmmunofluorescence A nalysis 
Cells were washed and resuspended in 50/~1 PBS containing saturating con- 
centrations of monoclonal antibody. After a 30-rain incubation on ice, cells 
were washed twice with 0.5%  BSA in PBS and resuspended in the same 
buffer containing optimal concentrations of FITC-labeled rabbit anti-rat im- 
munoglobulin (Nordic Immunological Laboratories, Tilburg, The Nether- 
lands). After 30 min on ice, cells were washed twice with 0.5 % BSA in PBS 
and resuspended in 0.5 ml of this buffer.  Fluorescence was analyzed with 
a  FACS IV flow sorter (Becton-Dickinson &  Co., Sunnyvale, CA). 
Metastatic Potential and Tumorigenicity 
Metastatic potential was assessed by injection of 106 cells into the tail vein 
of 6-10-wk-old syngeneic AKR mice. Animals were killed when moribund 
or after 100 d and examined for the presence of metastases. Tumorigenicity 
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Hybridoma Cells and LFA-l-deficient Mutants 
Monoclonal antibody 
Cell line  Anti-LFA-I  Anti-T200  Anti-Thy. 1 
TAM2D2  103.4  (2.0)  313.2  698.2 
2BI0  3.2  (2.2)  283.9  202.8 
1C9  3.0 (2.2)  284.4  2.2 
3D1  2.7  (1.9)  177.1  1.9 
IA4  2.3  (2.0)  146.4  359.4 
3C12  2.4 (2.1)  127.8  372.6 
Cells were stained with monoclonal antibodies specific for different cell surface 
antigens, as described.  Fluorescein-coupled rabbit anti-rat immunoglobulin 
was used as second reagent. Data are expressed in arbitrary units and represent 
the mean fluorescence detected in the presence of the corresponding mono- 
clonal antibody in a  representative experiment. Values in parentheses were 
obtained with negative control samples by omitting the incubation with mono- 
clonal antibody. The monoclonal antibodies M17/4, M1/9.3, and M5/49 were 
directed  against the  mouse antigens LFA-I  (u-chain),  T-200,  and  Thy. 1, 
respectively. 
was tested by subcutaneous injection of 106 cells in the neck region of AKR 
mice. 
Results 
Generation of  LFA-l-deficient Mutants 
Mutation of TAM2D2 T  cell hybridoma cells was accom- 
plished by treatment of the cells with the alkylating reagent 
ethyl methanesulfonate (0.4 mg/ml, 24 h). Initial cell death 
upon this treatment amounted to 70-90%. Viable cells were 
expanded and LFA-l-deficient variants were selected on cul- 
ture plates coated with anti-LFA-1  monoclonal antibody (pan- 
ning). Nonadhered cells were collected, expanded, and ana- 
lyzed by immunofluorescence for LFA-1 surface levels; the 
panning procedure was then repeated. After 6-10 rounds of 
selection, at least 50% of the cells exhibited substantially re- 
duced LFA-1 levels. After cloning by limiting dilution, we 
obtained five cell lines on which virtually no LFA-1 was pres- 
ent:  1C9, 2B10, 3D1,  1A4, and 3C12 (Table I). The mutants 
were screened for T200 and Thy.1  levels; T200 and Thy.1 
are two  surface antigens  which  are abundant  on parental 
TAM2D2 cells. Table I shows that the introduced mutations 
did not result in major changes in the T200 levels. All five 
mutants exhibited high T200 levels, although those of mu- 
tants 3D1,  1A4, and 3C12 were somewhat reduced in com- 
parison with TAM2D2 cells. The observed variability in the 
I200 levels of the mutants probably originates from clonal 
variation.  Three mutants  exhibited  high  Thy.1  levels,  al- 
though somewhat lower than TAM2D2 cells, but  1C9 and 
3D1 cells were Thy.1 deficient. The growth rates and DNA 
contents of all mutants  were essentially equal to those of 
TAM2D2 cells (Table II). As will be discussed later, the mu- 
tants were derived from at least three distinct mutant clones 
(Table III): type I (2B10), type II (1C9 and 3D1),  and type 
III (1A4 and 3C12). 
Table 11. Growth Rates and DNA Contents of TAM2D2 
T Cell Hybridoma Cells and LFA-l-deficient Mutant Cells 
Cell line  Doubling time  DNA content* 
h  % 
TAM2D2  11.7  +  0.6  182 
2BI0  10.9  +  2.6  186 
1  C9  ND  189 
1A4  10.1  +  0.7  187 
3C12  10.7  +  1.2  192 
The doubling times were calculated from the growth rates of exponentially 
growing cells. The DNA contents of cells were measured as described. Shown 
are the data of a representative experiment. 
* DNA contents are expressed as a percentage of that of BW5417 cells. 
experiments using  [35S]methionine.  For immunoprecipita- 
tions a rabbit antiserum was raised against afffinity-purified 
LFA-I. The antiserum immunoprecipitated the od/3 complex 
from NP-40 lysates of t25I-labeled TAM2D2 cells and the 
individual a and/3 subunits from SDS-denatured cell lysates, 
showing that the antiserum reacted with both subunits (not 
shown).  TAM2D2 parental or mutant cells were pulse-la- 
beled with  [35S]methionine  for  1 h  and then chased with 
unlabeled methionine for 15 h. The o~ and/3 chains were im- 
munoprecipitated from NP-40 cell lysates with the rabbit an- 
tiserum and Sepharose-coupled protein A.  TAM2D2 cells 
synthesized ot and /3 chain precursors of 170 and 93  kD, 
respectively (Fig.  1, A and B, lanes 1).  Upon chase, these 
precursors were converted to the mature 180-kD a chain and 
97-kD/3 chain (Fig. 1, A and B, lanes 2). A monoclonal an- 
tibody against the LFA-1 o~ chain immunoprecipitated ex- 
clusively the  ot chain precursor from pulse-labeled cells, 
whereas the od/3 complex was precipitated from chased cells 
(not shown). In agreement with observations by others (Ho 
and Springer, 1983; Springer et al., 1984), this demonstrates 
that the association of the LFA-1 a  and/3 chains occurs upon 
processing of the precursor forms. 
Pulse-chase studies with the obtained set of mutants re- 
vealed two different types of mutations  leading to LFA-1 
deficiency. Mutant cells 1C9, 2B10, and 3D1 did not synthe- 
size detectable amounts of a chain precursor (Fig. 1 A, lanes 
3,  5, and 9, respectively). Although the/3 chain precursor 
was  produced, the absence of the ot chain precursor pre- 
vented its processing to the higher molecular mass mature 
form, and during the 15-h chase it was degraded (Fig.  1 A, 
lanes 4, 6, and 8). An opposite type of mutation was found 
in mutants 1A4 (Fig. 1 B) and 3C12 (not shown); these mu- 
tants did not synthesize the/3 chain precursor although they 
did synthesize the ot chain precursor (Fig. 1 B, lane 3) which 
degraded during chase (Fig.  1 B, lane 4). 
Table IlL Classification of TAM2D2 Mutant Cell Lines 
Synthesis of LFA-1 
precursors 
Type of  Thy. I 
mutation  Cell line  surface level  u  Subunit  /3 Subunit 
Impaired Synthesis of  Either c~ or/3 Subunit Precursor  Type | 
in Different Mutants  Type II 
LFA-1 c¢ and/3 chain synthesis was assayed in pulse-chase  Type III 
2BlO  high  absent  normal 
1C9,  3D1  absent  absent  normal 
1A4,  3C12  high  normal  absent 
Roossien et al. Lymphoma Metastasis Dependent on LFA-1  1981 ~'gure 1. Immunoprecipitation of the LFA-1 subunit precursors from TAM2D2 T cell hybridoma cells and LFA-l-deficient mutants. TAM2D2 
and mutant cells were pulse-labeled with [3SS]methionine for 1 h with or without a 15-h chase, as indicated (A: TAM2D2 cells and 1C9, 
2B10, and 3D1 mutants; B: TAM2D2 cells and 1A4 mutant). The LFA-1 a  and fl subunits were immunoprecipitated from cell lysates with 
a rabbit anti-LFA-I antiserum and protein A-Sepharose.  From each iysate an aliquot was incubated with normal rabbit serum and protein 
A-Sepharose. Representative control immunoprecipitations are shown in lanes 5-8 (B). Samples were run on a 7.5 % SDS-polyacrylamide 
gel and subjected to fluorography, or' and#' indicate the c~ and fl subunit precursors, respectively. Only the indicated bands represent proteins 
specifically precipitated by the antiserum. 
Classification of  LFA-l-deficient Mutants 
Fluorescence analysis (Table I) and pulse-chase studies (Fig. 
1) enabled us to divide the obtained set of mutants into three 
distinct types (Table III). Type I and Type II mutants synthe- 
size the LFA-1/3 chain precursor, but do not produce the c~ 
chain precursor.  Type I  mutants have a  high Thy.1  expres- 
sion; type II mutants are Thy.1  deficient.  Type III mutants 
produce the LFA-1 c~ chain precursor, but do not synthesize 
the/3 chain precursor. 
Invasiveness of the Mutants in Hepatocyte Cultures 
The invasive potential of parental and mutant cells was as- 
sayed in vitro in hepatocyte monolayers, as described before 
(Roos and Van de Pavert,  1982).  5  x  1@ tumor cells were 
added to hepatocyte monolayers which had been cultured for 
24 h in 16-mm wells. After a 4 h incubation at 37°C, invasion 
was terminated by glutaraldehyde fixation. The monolayers 
were dehydrated, scraped off the culture dishes, and embed- 
ded in Epon. Sections were cut and stained, and the number 
of tumor cells  infiltrated  in  the  monolayers was  counted. 
Results were expressed as infiltration index,  a  measure for 
invasion  (for  further  details,  see  Materials  and  Methods; 
Roos and Van de Pavert, 1982), TAM2D2 cell infiltration of 
hepatocyte monolayers was inhibited by anti-LFA-1  mono- 
clonal antibody to  "~30%  of controls (Table IV;  Roos and 
Roossien, 1987).  The invasive potential of each of the three 
classes of LFA-l-deficient mutants was considerably lower 
than that of parental cells (Table IV) and comparable to that 
of parental cells in the presence of an excess of anti-LFA-1 
antibody. As expected, this limited invasiveness of the mu- 
tants was not further inhibited by the addition of anti-LFA-I 
monoclonal antibody. 
Table IV. Infiltration of TAM2D2 T Cell Hybridoma Cells 
and LFA-l-deficient Mutants into Hepatocyte Monolayers 
Infiltration index 
Anti-LFA-I monoclonal antibody 
Cell  line  -  + 
TAM2D2  0.79  0.25 
2B10  (type I)*  0.26  0.24 
1C9 (type II)  0.36  0.30 
1A4 (type III)  0.19  0.18 
3C12  (type III)  0.20  0.21 
TAM2D2 and mutant cell lines, preincubated with MI7/4 anti-LFA-I mono- 
clonal antibody (I/~g/ml) where indicated, were incubated for 4 h with hepato- 
cyte monolayers.  When cells were pretreated  with anti-LFA-I antibody, the 
antibody remained present during the incubation with hepatocytes, The infiltra- 
tion index was determined by counting cells in sections of embedded cultures, 
as described.  Shown are the data for one of several experiments with similar 
results. 
* Classification of mutants according to Table III. 
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and LFA-l-deficient Mutants into Fibroblast Monolayers 
Infiltration* 
Anti-LFA-I  monoclonal antibody 
Cell  line  -  + 
%  % 
TAM2D2  34  +  6  16  +  2 
2BlO  (type I)5  2  +  1  1  :t:  1 
IC9  (type II)  3  +  1  1  +  1 
IA4 (type III)  4  +  2  2  -t-  1 
3C12  (type III)  4  -k-  2  2  -I-  1 
TAM2D2 and mutant cells, preincubated with M17/4 anti-LFA-I monoclonal 
antibody (1 ttg/ml) where indicated,  were incubated for 4  h with rat embryo 
fibroblast  monolayers. The anti-LFA-l-treated cells were incubated  with fibro- 
blasts in the presence of the antibody.  Infiltrated  cells  were counted under the 
phase-contrast microscope. 
* The fraction  of infiltrated  cells,  expressed as a  percentage  of added  cells. 
:~ Classification  of mutants according to Table !II. 
lnvasiveness of the Mutants in Fibroblast Monolayers 
Recently it was shown that a number of T cell hybridomas, 
which were invasive in hepatocyte cultures, invade fibroblast 
monolayers as well (Collard et ai.,  1987; La Rivi~re et al., 
1988).  Invasiveness is easily quantitated in the phase-con- 
trast microscope by counting the number of tumor cells that 
have infiltrated into the fibroblast monolayers. Parental TAM- 
2D2 cells are highly invasive in these monolayers, and this 
process is inhibited to '~50% by anti-LFA-I monoclonal an- 
tibody (Table V). In comparison with parental cells, the inva- 
siveness of the LFA-l-deficient mutants was very low. Simi- 
lar results were obtained with each of the three distinct types 
of mutants. 
Metastatic Potential of the Mutants 
The metastatic potential of TAM2D2 parental  and mutant 
cell lines was tested by intravenous injection of the cells (Ta- 
ble VI).  In agreement with earlier results,  all animals  in- 
jected with TAM2D2 cells developed extensive metastasis 
(Roos et al.,  1985). Livers were heavily colonized and en- 
larged. Extrahepatic metastases were always found in ovaries 
and kidneys and frequently in lymph nodes, spleen, mesen- 
Table VI.  Metastatic Potential of TAM2D2 T Celt 
Hybridoma Cells and LFA-l-deficient  Mutants 
Moribund  Number of 
Number of  animals  animals that 
mice  killed  developed  Location of 
Cell  line  injected  at day  metastases*  metastases~  t 
TAM2D2  11  17-22  11  (100)  L,K,S,O,R 
2BI0  (type I)§  19  37-43  2  (11)  R  (L,K,O)II 
IC9  (type II)  22  37-46  2  (9)  R 
IA4 (type III)  10  -  0  (0)  - 
AKR  mice were  injected  with  106 cells  in the tail  vein.  Moribund animals 
were killed  atter the indicated number of days and analyzed for metastases. At 
day  I00 the experiment was terminated. 
* Values in parentheses indicate the percentage of injected  animals that devel- 
oped metastases during the  100-d  examination period. 
~: L,  liver;  K,  kidney;  S,  spleen;  O, ovaries; R,  retroperitoneal  (in the peri- 
toneal cavity behind the kidneys). 
§ Classification of mutants according to Table III. 
I1 Both animals contained  large  retroperitoneal  tumors.  In one animal  small 
tumors were detected  in the liver,  kidneys, and ovaries. 
terium, and in the peritoneal cavity. In contrast, the meta- 
static potential of the LFA-l-deficient mutants was consider- 
ably lower. From each of the three distinct types of mutants, 
one cell line was tested (Table VI). Only ~10%  of the in- 
jected animals developed metastases. In most cases a tumor 
mass was found in the peritoneal cavity behind the kidneys; 
in one animal small metastases were found in the liver, kid- 
neys, ovaries, and lymphoid organs. The remaining animals 
survived for at least 100 d, after which no macroscopic me- 
tastases were detected. The few metastases originating from 
the mutant cell lines developed more slowly than those of pa- 
rental cells (after 37-46 d instead of 17-22). All mutant cell 
lines were tumorigenic upon subcutaneous injection of cells. 
Parental  ceils developed large tumors in all animals  after 
'M2-14  d.  Tumors  of  similar  size  developed  somewhat 
slower in all animals injected with the mutant cells (i.e., after 
18-22 d). 
Discussion 
To elucidate invasion mechanisms of metastatic lymphoma 
cells, we used hepatocyte monolayers as an in vitro model. 
Lymphoma and T cell hybridoma cells that readily metasta- 
size to the  liver extensively invade such monolayers.  Re- 
cently we found that invasion of hepatocyte monolayers was 
inhibited by a monoclonal antibody against LFA-1 (Roos and 
Roossien,  1987). To demonstrate the direct involvement of 
LFA-1 in metastasis, we generated a set of LFA-l-deficient T 
cell hybridoma mutants. The reduced invasive and metastatic 
potential of  these mutants provide strong evidence that LFA-1 
has an important role in lymphoma metastasis. 
The cell line chosen to be mutated was the TAM2D2 T cell 
hybridoma that  exhibits  high  LFA-1 surface levels and  is 
highly invasive and metastatic (Roos et al.,  1985; Roos and 
Roossien, 1987). Treatment of TAM2D2 cells with the alkyl- 
ating reagent ethyl methanesulfonate, selection by panning, 
and subsequent cloning yielded a number of LFA-l-deficient 
mutants, among which three distinct types could be distin- 
guished  (Table III).  Type I  and II mutants  synthesize the 
precursor of the/3 chain but not the ~ chain of LFA-1. In type 
III mutants  the reverse was observed; cells synthesize the 
precursor of the c~ subunit but not of the 13 subunit.  Type I 
and type II mutants differ in Thy.1 expression, which is simi- 
lar to parental cells on type I but absent on type II mutant 
cells. Thus, the cell lines obtained were derived from at least 
three distinct mutant clones. 
The invasive potential of parental TAM2D2 cells, quanti- 
tated by their infiltration index, was reduced to "o30% in the 
presence of anti-LFA-1 monoclonal antibody. Since the inva- 
siveness of the mutant cell lines is comparable, this effect of 
the antibody was apparently not due to steric hindrance or 
induction of a negative signal (Martz et al.,  1983). The re- 
duced but substantial infiltration of the mutants and of paren- 
tal cells in the presence of anti-LFA-1 antibody shows that 
LFA-1 is not the only adhesion molecule involved. Inhibition 
by anti-LFA-1 antibody was previously found to result from 
a reduction in the number of tumor cells interacting with the 
hepatocyte monolayers,  since  the  fraction of the  reduced 
number of interacting cells that infiltrated the monolayers 
during the 4-h test was not diminished (Roos and Roossien, 
1987). This indicates that LFA-1 is involved in the initial step 
of invasion (i.e., in adhesion to the exposed hepatocyte sur- 
Roossien et al. Lymphoma Metastasis Dependent on LFA-I  1983 face) but not in the subsequent actual invasion step, the intru- 
sion between the hepatocytes. In agreement with this conclu- 
sion,  the reduced invasion of the LFA-l-deficient mutants 
was also due to decreased LFA-l-dependent adhesion to the 
hepatocyte monolayers (not shown). 
T cell hybridoma cells that invade hepatocyte monolayers 
also infiltrate rat embryo fibroblast monolayers (La Rivi~re 
et al.,  1988). The involvement of LFA-1 in the infiltration of 
such fibroblast cultures is demonstrated by the inhibition of 
TAM2D2 infiltration in the presence of anti-LFA-1 mono- 
clonal antibody, and the decreased infiltration of the LFA- 
1-deficient mutant cells (Table V). Because the adhesion of 
the tumor cells to the monolayers was relatively weak, the 
adhered  tumor cells  were  removed when the  monolayers 
were washed after incubation, and, therefore, adhesion could 
not be quantitated. However, in agreement with Dustin et al. 
(1986),  who have shown that pretreatment of lymphocytes 
with anti-LFA-1 antibody inhibits adhesion to dermal fibro- 
blasts,  we assume that the inhibition of the infiltration of 
TAM2D2  cells  in  rat  embryo fibroblast monolayers  also 
results from the inhibition of adhesion of the tumor cells to 
the exposed surface of the fibroblasts. As a consequence of 
this inhibited adhesion, subsequent infiltration of the tumor 
cells would also be inhibited. The decreased infiltration of 
the LFA-l-deficient mutants probably originates from their 
reduced LFA-l-dependent adhesion. 
The metastatic potential of the LFA-l-deficient TAM2D2 
mutants was *10-fold lower than that of parental cells (Table 
VI). Together with the observed reduction in invasive capac- 
ity of these mutants, this suggests that LFA-1 is involved in 
tumor cell metastasis by mediating adhesion to the extravas- 
cular surface of the cells in target tissues. Not only metastasis 
to the liver, but also to kidneys, ovaries, and lymphoid tis- 
sues, was reduced, indicating that LFA-1 is also required for 
efficient invasion into those tissues. This notion is supported 
by our finding that LFA-1 is also involved in infiltration of 
TAM2D2 T cell hybridoma ceils into fibroblast monolayers. 
Because anti-LFA-I monoclonal antibody inhibits not only 
the invasiveness of TAM2D2 T cell hybridoma cells, but also 
of spontaneously arisen highly metastatic MB6A lymphoma 
cells (Roos and Roossien,  1987), we suggest a similar role 
for LFA-1 in the metastasis of the latter cells. We are cur- 
rently investigating the LFA-1 cell surface expression of a 
number of lymphoma cells.  Until now, at least two highly 
metastatic lymphomas (i.e., ESb [Schirrmacher et al., 1979] 
and MDAY-D2 [Kerbel et al.,  1978]) were found to express 
the  antigen (not shown).  Probably LFA-1 is generally in- 
volved in the metastasis of highly metastatic lymphomas. 
Recently, we found within a set of different T cell hybrid- 
omas a close correlation between invasive potential, quanti- 
tated by the infiltration index (I) measured in hepatocyte cul- 
tures,  and  metastatic potential  (La Rivi~re et al.,  1988). 
Low-invasive cells (I <  0.13)  were not metastatic, whereas 
highly  invasive  cells  (I  =  0.53-2.08)  caused  widespread 
metastasis.  Intermediately  invasive  cells  (I  =  0.13-0.45) 
formed metastases in only a limited number of animals, pre- 
dominantly extrahepatically, mostly in lymphoid tissues. It 
is striking to note that this classification also holds for the 
presently described mutants. Based on their infiltration index 
(I  =  0.18-0.30), they belong to the intermediately invasive 
group, and they caused metastases in a limited number of 
animals, mainly at an extrahepatic site.  Taken together, this 
suggests that a certain threshold level of invasiveness is re- 
quired for widespread metastasis of this type of tumor cell. 
Probably the mutant cell lines described harbor more mu- 
tations than the one affecting LFA-1 synthesis. This is evident 
for type II mutants which are also deficient in Thy.1. For two 
reasons,  it  is  unlikely  that  the  change  in  invasive  and 
metastatic potential is caused by such additional mutations. 
First, because the reduction is similar for three distinct mu- 
tants that probably do not carry identical additional muta- 
tions.  Second,  because  all  mutants,  irrespective of class, 
infiltrate hepatocyte monolayers to the same extent as paren- 
tal cells in the presence of anti-LFA-I antibody. 
Recently, cloning of the human LFA-1 ~ gene has been de- 
scribed (Kishimoto et al.,  1987a;  Law et al.,  1987). We are 
presently attempting to transfect this gene into a  type III 
LFA-l-deficient mutant, in which/3 chain precursor synthe- 
sis  is absent. This should result in a transfectant that pro- 
duces LFA-I a  and ~ chain precursors from mouse and hu- 
man origin, respectively. It has been demonstrated that such 
precursors are  able  to associate and  mature to  a  human/ 
mouse interspecies LFA-1 that is expressed on the cell sur- 
face (Marlin et al., 1986). If this LFA-1 species is functional, 
the behavior of such a  transfectant will hopefully provide 
definite proof that the reduced invasive potential in vitro and 
metastatic capacity in vivo of the mutants are due to LFA-1 
deficiency. 
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